PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
Prenetics Global Ltd
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2026
$19.02+0.50 (+2.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.02 (+26.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Prenetics Global Ltd grew revenue 40.8% to $30.62M over fiscal 2024. Free cash flow was -$29.88M.
Revenue
$30.62M
+40.8% vs. a year earlier
Operating income
-$48.14M
FY2024
Free cash flow
-$29.88M
FY2024
EPS, diluted
-$3.71
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $30.62M
- Net income
- -$46.30M
- EPS, diluted
- -$3.71
- Free cash flow
- -$29.88M
Six years at a glance
Fiscal years 2019 to 2024, USD
Revenue
$30.62M+40.8% YoY
Gross profit
$15.40M+74.4% YoY
Operating income
-$48.14M
Net income
-$46.30M
EPS, diluted
-$3.71
Free cash flow
-$29.88M
Reported period